NSE: PIIND · 9 November 2026
- Pi Industries has fallen 21.68% over 3 trading sessions; today's move is -2.16%.
- PI Industries announced the unveiling of Pioxaniliprole, recognized by the Central Insecticides Board and Registration Committee as India's first indigenously discovered and developed insecticide active ingredient. Developed over a decade of research by over 700 scientists, the molecule has received domestic registration under Section 9(3) of the Insecticides Act, 1968.
- Trading volume was 1.80 times the 20-day average daily volume.
Pi Industries share price: 21.68% decline over 3 trading sessions
PI Industries Ltd (PIIND) declined by 2.16% today, settling at ₹1,712.90 after moving within a intraday range of ₹1,699.40 to ₹1,742.20.
The broader market showed a muted trend as the Nifty benchmark edged up by 0.06%, while the Nifty Metal sector slipped 0.11%. The stock's downward movement aligns with ongoing sectoral headwinds affecting export demand in the agrochemical space, though it continues to trade near its 52-week low of ₹1,699.40.
Company disclosures provide ongoing fundamental context following the release of September 30, 2026 quarterly results, which highlighted a 9% decline in consolidated revenue to ₹1,701.8 crores and a drop in EBITDA to ₹236.2 crores due to pricing pressures and higher input costs in agchem exports. However, recent developments also feature the regulatory approval and unveiling of Pioxaniliprole, India's first indigenously discovered insecticide molecule, alongside the incorporation of PI Foundation as a wholly owned subsidiary for corporate social responsibility initiatives.
16.08 lakh shares traded by 9 November 2026 · 03:30 PM IST. This compares with a 20-day average daily volume of 8.92 lakh shares (1.80 times). The five-day average daily volume was 26.90 lakh shares. Separately, the NSE report for 9 November 2026 showed 6.45 lakh shares delivered, representing 40.13% of that day’s traded volume. The same report recorded 68,679 trades.
The stock declined by 2.16% on above-average volume, touching a fresh 52-week low of ₹1,699.40. This price action reflects ongoing investor caution regarding global agrochemical pricing pressures and export headwinds noted in recent earnings, rather than a single isolated daily catalyst.
Latest Company Developments
PI Industries announced the unveiling of Pioxaniliprole, recognized by the Central Insecticides Board and Registration Committee as India's first indigenously discovered and developed insecticide active ingredient. Developed over a decade of research by over 700 scientists, the molecule has received domestic registration under Section 9(3) of the Insecticides Act, 1968.
It marks a historic technological milestone for Indian agricultural science and reinforces the company's long-term capability to originate proprietary intellectual property.
The company reported its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, showing consolidated revenue of ₹1,701.8 crores and net profit of ₹122.2 crores. Management noted that while agchem exports faced headwinds from lower global demand and genericization, domestic revenues grew 19% and biologicals expanded significantly.
Earnings updates directly impact valuation by showcasing how domestic momentum and biological segments offset international agrochemical pricing pressures.
The company completed the incorporation of PI Foundation as a wholly owned subsidiary under Section 8 of the Companies Act, 2013, with an initial cash share capital subscription of ₹1,00,000. The entity is established to carry out corporate social responsibility activities.
Formalizes the company's governance structure for dedicated social impact and community development initiatives.
PI Industries Limited has submitted to the Exchange, the Outcome of Board Meeting held on November 04, 2026 for approval of Unaudited Standalone and Consolidated Financial Results for the quarter and half year September 30, 2026.
Update on Incorporation of a Wholly Owned Subsidiary of the Company namely PI Foundation under section 8 of the Companies Act, 2013.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 22.18% on 30 September 2026. This compares with 22.31% on 30 June 2026, a change of -0.13 percentage points.
The filing reported 30 MF/UTI holders.
Historical Bulk / Block Deals
What to Watch Next
- Execution and commercial scale-up of newly launched indigenous insecticide Pioxaniliprole in domestic and international markets
- Performance of the biologicals and health sciences segments in upcoming quarters to offset agchem export headwinds
- Further trends in trade working capital reduction and cash conversion efficiency
- Delivery volume trends relative to the 20-day average volume of 1.8x to gauge institutional participation
Other Dated Coverage
- Pi Industries Share Price Today: Falls 20.67% in 2 Trading Sessions | 6 November 2026 — 6 November 2026
- Pi Industries Share Price Today: Why PIIND Is Rising 3.27% | 27 October 2026 — 27 October 2026
- Pi Industries Share Price Today: Why PIIND Is Falling 1.15% | 23 October 2026 — 23 October 2026
More Pi Industries news and dated analysis →
Frequently Asked Questions
What is the latest Pi Industries company news?
PI Industries announced the unveiling of Pioxaniliprole, recognized by the Central Insecticides Board and Registration Committee as India's first indigenously discovered and developed insecticide active ingredient. Developed over a decade of research by over 700 scientists, the molecule has received domestic registration under Section 9(3) of the Insecticides Act, 1968.
How strong was Pi Industries’s trading volume?
16.08 lakh shares traded, 1.80 times the 20-day average daily volume. The price and volume data are dated 9 November 2026 · 03:30 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.